Primary pancreatic cystic neoplasms revisited. Part I

Serous cystic neoplasms

George H. Sakorafas, Vasileios Smyrniotis, Kaye M. Reid-Lombardo, Michael G. Sarr

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Primary pancreatic cystic neoplasms have been recognized increasingly during the two recent decades and include mainly serous cystic neoplasms, mucinous cystic neoplasms, and intraductal papillary mucinous neoplasms. Serous cystic neoplasms represent about 30% of all cystic neoplasms of the pancreas and are characterized by their microcystic appearance (on imaging, macroscopically, and microscopically) and their benign biologic behavior. Modern diagnostic methodology allows the preoperative diagnosis with an acceptable accuracy. Currently, indications for resection of serous cystic neoplasms of the pancreas include the presence of symptoms, size > 4 cm (because these 'large' neoplasms have a more rapid growth rate and probably will soon become symptomatic), and any uncertainty about the diagnosis of a serous versus a mucinous cystic neoplasm. Resection should also be considered for lesions in the body/tail of the pancreas. Conservative treatment is a reasonable option in selected patients (for example in the presence of small, asymptomatic lesions in the pancreatic head, especially in the frail or elderly patient).

Original languageEnglish (US)
JournalSurgical Oncology
Volume20
Issue number2
DOIs
StatePublished - Jun 2011

Fingerprint

Pancreatic Neoplasms
Neoplasms
Neoplasms, Cystic, Mucinous, and Serous
Frail Elderly
Uncertainty
Pancreas
Growth

Keywords

  • Cystic neoplasm of the pancreas
  • Intraductal papillary mucinous neoplasm
  • Mucinous cystic neoplasm
  • Serous cystadenocarcinoma
  • Serous cystadenoma

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Primary pancreatic cystic neoplasms revisited. Part I : Serous cystic neoplasms. / Sakorafas, George H.; Smyrniotis, Vasileios; Reid-Lombardo, Kaye M.; Sarr, Michael G.

In: Surgical Oncology, Vol. 20, No. 2, 06.2011.

Research output: Contribution to journalArticle

Sakorafas, George H. ; Smyrniotis, Vasileios ; Reid-Lombardo, Kaye M. ; Sarr, Michael G. / Primary pancreatic cystic neoplasms revisited. Part I : Serous cystic neoplasms. In: Surgical Oncology. 2011 ; Vol. 20, No. 2.
@article{f7a2754b771b432c9d100511c67e43be,
title = "Primary pancreatic cystic neoplasms revisited. Part I: Serous cystic neoplasms",
abstract = "Primary pancreatic cystic neoplasms have been recognized increasingly during the two recent decades and include mainly serous cystic neoplasms, mucinous cystic neoplasms, and intraductal papillary mucinous neoplasms. Serous cystic neoplasms represent about 30{\%} of all cystic neoplasms of the pancreas and are characterized by their microcystic appearance (on imaging, macroscopically, and microscopically) and their benign biologic behavior. Modern diagnostic methodology allows the preoperative diagnosis with an acceptable accuracy. Currently, indications for resection of serous cystic neoplasms of the pancreas include the presence of symptoms, size > 4 cm (because these 'large' neoplasms have a more rapid growth rate and probably will soon become symptomatic), and any uncertainty about the diagnosis of a serous versus a mucinous cystic neoplasm. Resection should also be considered for lesions in the body/tail of the pancreas. Conservative treatment is a reasonable option in selected patients (for example in the presence of small, asymptomatic lesions in the pancreatic head, especially in the frail or elderly patient).",
keywords = "Cystic neoplasm of the pancreas, Intraductal papillary mucinous neoplasm, Mucinous cystic neoplasm, Serous cystadenocarcinoma, Serous cystadenoma",
author = "Sakorafas, {George H.} and Vasileios Smyrniotis and Reid-Lombardo, {Kaye M.} and Sarr, {Michael G.}",
year = "2011",
month = "6",
doi = "10.1016/j.suronc.2010.12.002",
language = "English (US)",
volume = "20",
journal = "Surgical Oncology",
issn = "0960-7404",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - Primary pancreatic cystic neoplasms revisited. Part I

T2 - Serous cystic neoplasms

AU - Sakorafas, George H.

AU - Smyrniotis, Vasileios

AU - Reid-Lombardo, Kaye M.

AU - Sarr, Michael G.

PY - 2011/6

Y1 - 2011/6

N2 - Primary pancreatic cystic neoplasms have been recognized increasingly during the two recent decades and include mainly serous cystic neoplasms, mucinous cystic neoplasms, and intraductal papillary mucinous neoplasms. Serous cystic neoplasms represent about 30% of all cystic neoplasms of the pancreas and are characterized by their microcystic appearance (on imaging, macroscopically, and microscopically) and their benign biologic behavior. Modern diagnostic methodology allows the preoperative diagnosis with an acceptable accuracy. Currently, indications for resection of serous cystic neoplasms of the pancreas include the presence of symptoms, size > 4 cm (because these 'large' neoplasms have a more rapid growth rate and probably will soon become symptomatic), and any uncertainty about the diagnosis of a serous versus a mucinous cystic neoplasm. Resection should also be considered for lesions in the body/tail of the pancreas. Conservative treatment is a reasonable option in selected patients (for example in the presence of small, asymptomatic lesions in the pancreatic head, especially in the frail or elderly patient).

AB - Primary pancreatic cystic neoplasms have been recognized increasingly during the two recent decades and include mainly serous cystic neoplasms, mucinous cystic neoplasms, and intraductal papillary mucinous neoplasms. Serous cystic neoplasms represent about 30% of all cystic neoplasms of the pancreas and are characterized by their microcystic appearance (on imaging, macroscopically, and microscopically) and their benign biologic behavior. Modern diagnostic methodology allows the preoperative diagnosis with an acceptable accuracy. Currently, indications for resection of serous cystic neoplasms of the pancreas include the presence of symptoms, size > 4 cm (because these 'large' neoplasms have a more rapid growth rate and probably will soon become symptomatic), and any uncertainty about the diagnosis of a serous versus a mucinous cystic neoplasm. Resection should also be considered for lesions in the body/tail of the pancreas. Conservative treatment is a reasonable option in selected patients (for example in the presence of small, asymptomatic lesions in the pancreatic head, especially in the frail or elderly patient).

KW - Cystic neoplasm of the pancreas

KW - Intraductal papillary mucinous neoplasm

KW - Mucinous cystic neoplasm

KW - Serous cystadenocarcinoma

KW - Serous cystadenoma

UR - http://www.scopus.com/inward/record.url?scp=79954587962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79954587962&partnerID=8YFLogxK

U2 - 10.1016/j.suronc.2010.12.002

DO - 10.1016/j.suronc.2010.12.002

M3 - Article

VL - 20

JO - Surgical Oncology

JF - Surgical Oncology

SN - 0960-7404

IS - 2

ER -